Germany vs Mozambique: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Germany
74.0%
in 2025
Mozambique
70.0%
in 2025
Germany rank
131st
Mozambique rank
134th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Germany
- Mozambique
How they compare
Germany currently reports 74.0% against 70.0% in Mozambique, a difference of 4.0%.
That makes Germany's figure about 1.1 times Mozambique's.
Across all 18 years both countries report, Germany has been ahead every year.
Germany ranks 131st and Mozambique ranks 134th of 194 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 0.0% | 76.0% | Germany |
| 2010s | 83.2% | 52.1% | 31.1% | Germany |
| 2020s | 76.5% | 64.8% | 11.7% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Germany or Mozambique?
- Germany, at 74.0% against 70.0% in Mozambique as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Germany and Mozambique?
- 4.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Mozambique?
- 18 years are reported by both, from 2008 to 2025.
- How do Germany and Mozambique rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Germany ranks 131st and Mozambique ranks 134th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.